Global Oligonucleotide Market Growth 2025-2031

Publication ID:

LPI01251468

Publication Date:

January 27, 2025

Pages:

110

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Manufacturing (Chemicals) [2]

Chemicals [3]

Description:

The global Oligonucleotide market size is predicted to grow from US$ 1494 million in 2025 to US$ 2716 million in 2031; it is expected to grow at a CAGR of 10.5% from 2025 to 2031.
Oligonucleotides are short nucleic acid polymers used in research, genetic testing and forensics.

Oligonucleotides are usually made up of 13 to 25 nucleotides and are designed to hybridize specifically to DNA or RNA sequences. Solid-phase clinical synthesis is used to manufacture these small bits of nucleic acid for use in polymerase chain reaction (PCR), DNA sequencing, library construction and artificial gene synthesis.
Oligonucleotide drugs have the advantages of high therapeutic efficiency, low drug toxicity, and strong specificity, and have great potential in the treatment of metabolic diseases, genetic diseases, cancer, and prevention of infectious diseases. In recent years, due to the unique advantages of oligonucleotides in regulating gene expression, the research and development, production and commercialization of their drugs have developed rapidly, and the global market has continued to expand.
The 鈥淥ligonucleotide Industry Forecast鈥� looks at past sales and reviews total world Oligonucleotide sales in 2024, providing a comprehensive analysis by region and market sector of projected Oligonucleotide sales for 2025 through 2031. With Oligonucleotide sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oligonucleotide industry.
This Insight Report provides a comprehensive analysis of the global Oligonucleotide landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Oligonucleotide portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Oligonucleotide market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oligonucleotide and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oligonucleotide.
This report presents a comprehensive overview, market shares, and growth opportunities of Oligonucleotide market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
DNA
RNA
Segmentation by Application:
Gene Chip
Electrophoresis
Fluorescence In Situ Hybridization
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Abbott Molecular
PerkinElmer
SciGene Corporation
Roche NimbleGen
CytoTest
Oligo Factory
Danaher
Thermo Fisher Scientific
GE
Merck
Eurofins Scientific
Agilent
SUMITOMO CHEMICAL
Bachem
Sylentis
Key Questions Addressed in this Report
What is the 10-year outlook for the global Oligonucleotide market?
What factors are driving Oligonucleotide market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Oligonucleotide market opportunities vary by end market size?
How does Oligonucleotide break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Oligonucleotide Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Oligonucleotide by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Oligonucleotide by Country/Region, 2020, 2024 & 2031
2.2 Oligonucleotide Segment by Type
2.2.1 DNA
2.2.2 RNA
2.3 Oligonucleotide Sales by Type
2.3.1 Global Oligonucleotide Sales Market Share by Type (2020-2025)
2.3.2 Global Oligonucleotide Revenue and Market Share by Type (2020-2025)
2.3.3 Global Oligonucleotide Sale Price by Type (2020-2025)
2.4 Oligonucleotide Segment by Application
2.4.1 Gene Chip
2.4.2 Electrophoresis
2.4.3 Fluorescence In Situ Hybridization
2.5 Oligonucleotide Sales by Application
2.5.1 Global Oligonucleotide Sale Market Share by Application (2020-2025)
2.5.2 Global Oligonucleotide Revenue and Market Share by Application (2020-2025)
2.5.3 Global Oligonucleotide Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Oligonucleotide Breakdown Data by Company
3.1.1 Global Oligonucleotide Annual Sales by Company (2020-2025)
3.1.2 Global Oligonucleotide Sales Market Share by Company (2020-2025)
3.2 Global Oligonucleotide Annual Revenue by Company (2020-2025)
3.2.1 Global Oligonucleotide Revenue by Company (2020-2025)
3.2.2 Global Oligonucleotide Revenue Market Share by Company (2020-2025)
3.3 Global Oligonucleotide Sale Price by Company
3.4 Key Manufacturers Oligonucleotide Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Oligonucleotide Product Location Distribution
3.4.2 Players Oligonucleotide Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Oligonucleotide by Geographic Region
4.1 World Historic Oligonucleotide Market Size by Geographic Region (2020-2025)
4.1.1 Global Oligonucleotide Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Oligonucleotide Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Oligonucleotide Market Size by Country/Region (2020-2025)
4.2.1 Global Oligonucleotide Annual Sales by Country/Region (2020-2025)
4.2.2 Global Oligonucleotide Annual Revenue by Country/Region (2020-2025)
4.3 Americas Oligonucleotide Sales Growth
4.4 APAC Oligonucleotide Sales Growth
4.5 Europe Oligonucleotide Sales Growth
4.6 Middle East & Africa Oligonucleotide Sales Growth
5 Americas
5.1 Americas Oligonucleotide Sales by Country
5.1.1 Americas Oligonucleotide Sales by Country (2020-2025)
5.1.2 Americas Oligonucleotide Revenue by Country (2020-2025)
5.2 Americas Oligonucleotide Sales by Type (2020-2025)
5.3 Americas Oligonucleotide Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oligonucleotide Sales by Region
6.1.1 APAC Oligonucleotide Sales by Region (2020-2025)
6.1.2 APAC Oligonucleotide Revenue by Region (2020-2025)
6.2 APAC Oligonucleotide Sales by Type (2020-2025)
6.3 APAC Oligonucleotide Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Oligonucleotide by Country
7.1.1 Europe Oligonucleotide Sales by Country (2020-2025)
7.1.2 Europe Oligonucleotide Revenue by Country (2020-2025)
7.2 Europe Oligonucleotide Sales by Type (2020-2025)
7.3 Europe Oligonucleotide Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Oligonucleotide by Country
8.1.1 Middle East & Africa Oligonucleotide Sales by Country (2020-2025)
8.1.2 Middle East & Africa Oligonucleotide Revenue by Country (2020-2025)
8.2 Middle East & Africa Oligonucleotide Sales by Type (2020-2025)
8.3 Middle East & Africa Oligonucleotide Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Oligonucleotide
10.3 Manufacturing Process Analysis of Oligonucleotide
10.4 Industry Chain Structure of Oligonucleotide
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Oligonucleotide Distributors
11.3 Oligonucleotide Customer
12 World Forecast Review for Oligonucleotide by Geographic Region
12.1 Global Oligonucleotide Market Size Forecast by Region
12.1.1 Global Oligonucleotide Forecast by Region (2026-2031)
12.1.2 Global Oligonucleotide Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Oligonucleotide Forecast by Type (2026-2031)
12.7 Global Oligonucleotide Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Abbott Molecular
13.1.1 Abbott Molecular Company Information
13.1.2 Abbott Molecular Oligonucleotide Product Portfolios and Specifications
13.1.3 Abbott Molecular Oligonucleotide Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Abbott Molecular Main Business Overview
13.1.5 Abbott Molecular Latest Developments
13.2 PerkinElmer
13.2.1 PerkinElmer Company Information
13.2.2 PerkinElmer Oligonucleotide Product Portfolios and Specifications
13.2.3 PerkinElmer Oligonucleotide Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 PerkinElmer Main Business Overview
13.2.5 PerkinElmer Latest Developments
13.3 SciGene Corporation
13.3.1 SciGene Corporation Company Information
13.3.2 SciGene Corporation Oligonucleotide Product Portfolios and Specifications
13.3.3 SciGene Corporation Oligonucleotide Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 SciGene Corporation Main Business Overview
13.3.5 SciGene Corporation Latest Developments
13.4 Roche NimbleGen
13.4.1 Roche NimbleGen Company Information
13.4.2 Roche NimbleGen Oligonucleotide Product Portfolios and Specifications
13.4.3 Roche NimbleGen Oligonucleotide Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Roche NimbleGen Main Business Overview
13.4.5 Roche NimbleGen Latest Developments
13.5 CytoTest
13.5.1 CytoTest Company Information
13.5.2 CytoTest Oligonucleotide Product Portfolios and Specifications
13.5.3 CytoTest Oligonucleotide Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 CytoTest Main Business Overview
13.5.5 CytoTest Latest Developments
13.6 Oligo Factory
13.6.1 Oligo Factory Company Information
13.6.2 Oligo Factory Oligonucleotide Product Portfolios and Specifications
13.6.3 Oligo Factory Oligonucleotide Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Oligo Factory Main Business Overview
13.6.5 Oligo Factory Latest Developments
13.7 Danaher
13.7.1 Danaher Company Information
13.7.2 Danaher Oligonucleotide Product Portfolios and Specifications
13.7.3 Danaher Oligonucleotide Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Danaher Main Business Overview
13.7.5 Danaher Latest Developments
13.8 Thermo Fisher Scientific
13.8.1 Thermo Fisher Scientific Company Information
13.8.2 Thermo Fisher Scientific Oligonucleotide Product Portfolios and Specifications
13.8.3 Thermo Fisher Scientific Oligonucleotide Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Thermo Fisher Scientific Main Business Overview
13.8.5 Thermo Fisher Scientific Latest Developments
13.9 GE
13.9.1 GE Company Information
13.9.2 GE Oligonucleotide Product Portfolios and Specifications
13.9.3 GE Oligonucleotide Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 GE Main Business Overview
13.9.5 GE Latest Developments
13.10 Merck
13.10.1 Merck Company Information
13.10.2 Merck Oligonucleotide Product Portfolios and Specifications
13.10.3 Merck Oligonucleotide Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Merck Main Business Overview
13.10.5 Merck Latest Developments
13.11 Eurofins Scientific
13.11.1 Eurofins Scientific Company Information
13.11.2 Eurofins Scientific Oligonucleotide Product Portfolios and Specifications
13.11.3 Eurofins Scientific Oligonucleotide Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Eurofins Scientific Main Business Overview
13.11.5 Eurofins Scientific Latest Developments
13.12 Agilent
13.12.1 Agilent Company Information
13.12.2 Agilent Oligonucleotide Product Portfolios and Specifications
13.12.3 Agilent Oligonucleotide Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Agilent Main Business Overview
13.12.5 Agilent Latest Developments
13.13 SUMITOMO CHEMICAL
13.13.1 SUMITOMO CHEMICAL Company Information
13.13.2 SUMITOMO CHEMICAL Oligonucleotide Product Portfolios and Specifications
13.13.3 SUMITOMO CHEMICAL Oligonucleotide Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 SUMITOMO CHEMICAL Main Business Overview
13.13.5 SUMITOMO CHEMICAL Latest Developments
13.14 Bachem
13.14.1 Bachem Company Information
13.14.2 Bachem Oligonucleotide Product Portfolios and Specifications
13.14.3 Bachem Oligonucleotide Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Bachem Main Business Overview
13.14.5 Bachem Latest Developments
13.15 Sylentis
13.15.1 Sylentis Company Information
13.15.2 Sylentis Oligonucleotide Product Portfolios and Specifications
13.15.3 Sylentis Oligonucleotide Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Sylentis Main Business Overview
13.15.5 Sylentis Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂